Bio-Rad Laboratories, Inc.Class A vs. Precipio, Inc. Common Stock
BIO
Bio-Rad Laboratories, Inc.Class A
$382.41 +0.89%
VS PRPOPrecipio, Inc. Common Stock
$27.32 +1.52%
Bio-Rad Laboratories, Inc.Class A (BIO) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| BIO | PRPO | |
|---|---|---|
| Market Cap | $10.13 billion | $48.17 million |
| Revenue (TTM) | $2.59 billion | — |
| Net Income (TTM) | $222.40 million | — |
BIO leads on 1 of 1 size & scale factors.
Valuation
| BIO | PRPO | |
|---|---|---|
| P/E Ratio | 46.58 | — |
| Price / Book | 1.41 | — |
| Price / Sales | 3.91 | — |
BIO and PRPO split the valuation factors evenly.
Profitability
| BIO | PRPO | |
|---|---|---|
| Net Margin | 8.59% | — |
| Return on Equity | 3.10% | — |
BIO and PRPO split the profitability factors evenly.
Risk & Sentiment
| BIO | PRPO | |
|---|---|---|
| Short Interest | 2.44% | 5.42% |
BIO leads on 1 of 1 risk & sentiment factors.
Dig deeper: BIO overview, BIO financials, PRPO overview, PRPO financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.